Evaluation of the PPAR-[gamma] agonist pioglitazone in mild asthma: A double-blind randomized controlled trial

Peroxisome proliferator-activated receptor gamma (PPAR-[gamma]) is a nuclear receptor that modulates inflammation in models of asthma. To determine whether pioglitazone improves measures of asthma control and airway inflammation, we performed a single-center randomized, double-blind, placebo-control...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	PloS one Jg. 11; H. 8; S. e0160257
Hauptverfasser:	Anderson, J. R, Mortimer, K, Pang, L, Smith, K. M, Bailey, H, Hodgson, D. B, Shaw, D. E, Knox, A. J, Harrison, T. W
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Public Library of Science 25.08.2016
Schlagworte:	Asthma Care and treatment Clinical trials Complications and side effects Health aspects Influence Pioglitazone Vascular endothelial growth factor United Kingdom
ISSN:	1932-6203, 1932-6203
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!